Free Newsletter
Deal yields single-use fluid-management solutions
A deal said to move the totally disposable bioprocessing factory "one step closer to reality" has been struck by single-use bioprocessing equipment and services supplier Sartorius Stedim Biotech and SAFC Biosciences, a provider of cell culture materials and development services for upstream and downstream processing.
The agreement combines Sartorius Stedim Biotech's capabilities in filtration and liquid handling systems with SAFC Biosciences' proficiency in the development and manufacturing of cell culture media and downstream purification products, according to an announcement. The partners aim to capture and analyze data from the combined filtration and buffer technologies. They will also provide data on media buffer extractability and leachability.
Each company will offer its products with the support of its partner to serve customers in solution creation, validation support, process improvement and technical support, the announcement says.
- here's the announcement
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

SHARE
WITH: